Filing Details
- Accession Number:
- 0000899243-20-032306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-30 16:34:32
- Reporting Period:
- 2020-11-25
- Accepted Time:
- 2020-11-30 16:34:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1823239 | Maravai Lifesciences Holdings Inc. | MRVI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1205465 | Carl Hull | C/O Maravai Lifesciences Holdings, Inc. 10770 Wateridge Circle, Suite 200 San Diego CA 92121 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2020-11-25 | 35,000 | $26.94 | 35,000 | No | 4 | P | Indirect | Through Glossatori, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Through Glossatori, LLC |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.81 to $27.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.